A Message From IMF President and CEO, Yelak Biru

Watch IMF President and CEO—as well as 27-year multiple myeloma survivor—Yelak Biru reflect on the impact of the IMF in 2022 and share his vision for the future.


The IMF's impact in 2022
Read the 2022 IMF Impact Report

Because of your support, the International Myeloma Foundation (IMF) made huge strides in myeloma research, education, support, and advocacy in 2022. Read the full impact report now. 

Image Left
2022 Research Highlights
In 2022, the IMF showcased
10 abstracts
with data from iStopMM at the 2022 American Society of Hematology meeting.
The U.S. based ASCENT trial showcased that
had an overall response in this treatment protocol and that 84% had MRD-negative status.
Dr. Brian G.M. Durie discusses the importance of raising myeloma awareness
Dr. Brian G.M. Durie
IMF Chairman of the Board and Chief Scientific Officer
“For more than 30 years, the IMF has been on a mission to improve the lives of myeloma patients and find a cure. We believe that the early treatment strategies that underpin the iStopMM Project, the ASCENT trial, and The CESAR trial together hold the key to achieving the cure.”
2022 Education Highlights
The IMF translated nearly
60 publications
into 19 different languages,
44,000+ publications
to patients, care partners, and healthcare workers.
Awareness Initiatives
Myeloma ACTION Month reached
30 million
across 46 countries around the world.
Blood Cancer Awareness Month reached
17.8 million
across 36 countries and was a resounding success.
IMF CEO Yelak Biru
Yelak Biru
IMF Patient, President and CEO
“I believe hope is the anchor that keeps our ship floating and keeps it from drifting in the storm. Hope is necessary for anyone who is facing a cancer diagnosis. But hope requires a plan; hope without a plan of action is just a dream.”
2022 Support Highlights
inquiries responded by the IMF InfoLine.
of patients connected with the IMF through 942 virtual support group visits.
Leaders educated and Inspired at the 23rd IMF Support Group Leader Summit.
2022 Advocacy Highlights
The IMF united more than
30 countries
to improve access to myeloma care worldwide.
The IMF mobilized more than
100 advocates
to take legislative action in the U.S.
Sign Up Now and Stay Up-to-Date
Don’t Miss a Thing in 2023
Sign up for the myeloma minute weekly e-newsletter.
Read the Full 2022 Impact Report

Read the full IMF Impact Report and discover what you made possible in 2022. 

The impact of the IMF in 2022
Image Left

Give Where Most Needed

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt-out click for more information.